PXD017125 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Ligustilide targets SMAD3, obstructing vascular fibrosis process in preventing atherosclerosis |
Description | Atherosclerosis is a persistent inflammatory state accompanied by lipid overload. Vascular fibrosis is one of the primary causes of atherosclerosis development. Although ligustilide (Lig) was shown to exert obvious antiatherogenic effects in previous studies, its precise mechanism has not been comprehensively discussed. In this paper, pharmacologic studies were performed to explore the pharmacodynamic effects of Lig on protecting aorta vascular wall structures and modulating serum inflammatory factors in ApoE-/- mice. Chemical proteomics based on a Lig-derived photoaffinity labelling (Lig-PAL) probe were applied to identify potential therapeutic targets. Mothers against decapentaplegic homologue 3 (SMAD3), which is closely related to the development of vascular fibrosis and atherosclerosis, was identified as a potential target of Lig. Lig suppressed the phosphorylation and nuclear translocation of SMAD3 by blocking the interaction between SMAD3 and transforming growth factor-β (TGF-β) receptor 1, thereby inhibiting the collagen synthesis process, preventing vascular fibrosis and improving atherosclerosis. The quantitative proteomics results from Lig-treated atherosclerotic ApoE-/- mice also indicated that Lig inhibits the expression of collagens I and III, interferes with collagen fibril organization processes and protects the aorta from vascular fibrosis. Hence, developing a novel SMAD3 inhibitor may present another therapeutic option for preventing atherosclerosis. |
HostingRepository | PRIDE |
AnnounceDate | 2020-01-21 |
AnnouncementXML | Submission_2020-01-21_01:58:55.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Wei Lei |
SpeciesList | scientific name: Mus musculus (Mouse); NCBI TaxID: 10090; |
ModificationList | No PTMs are included in the dataset |
Instrument | Q Exactive Plus |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2020-01-15 05:45:57 | ID requested | |
⏵ 1 | 2020-01-21 01:58:56 | announced | |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: Ligustilide |
SMAD3 |
atherosclerosis |
vascular fibrosis |
chemical proteomics |
Contact List
Wei Lei |
contact affiliation | State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300353, People’s Republic of China |
contact email | l_wei8910@163.com |
lab head | |
Wei Lei |
contact affiliation | NanKai Univeristy |
contact email | l_wei8910@163.com |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD017125 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD017125
- Label: PRIDE project
- Name: Ligustilide targets SMAD3, obstructing vascular fibrosis process in preventing atherosclerosis